Bleeding events (mostly haematoma) were common as expected in this patient population with a high proportion of patients taking anticoagulant co-medication.
Veritsusjuhud (peamiselt hematoomid) olid sagedased, nagu oligi oodata selliste patsientide puhul, kes tarvitasid kaasravimina antikoagulante.